Skip to content
Click “Review Lead” to view the info and about the lead.Qualify/Backlog/Disqualify the lead
Share
Explore
Add & Qualify Companies
Review your AI Qualified Leads ✨
As companies are entered into the table below they will be automatically prioritized and qualified based on what you’ve told us in and . To learn more you can check out the prompts in AI Priority and AI Analysis, to view a prompt simply hover over the header, click the dropdown or right click and click “✨ Edit AI ”.
Broken link
Broken link
From this page:
Clear Sample Rows
Add row
Companies
AI Priority ✨
Logo
Company
Review Lead
AI Analysis ✨
HQ Location
Description
Domain
[AI Analysis ✨]
24
Zip
Review
Qualified: The company Zip meets all the criteria for qualification. The target industry includes finance and information technology, the company has 50-500 employees, and the funding stage is Series C. Although the funding amount is not specified, the company's description suggests that it has significant financing.
San Francisco, California, USA
Zip is an Intake-to-Pay platform for any employee to initiate a purchase or vendor request.
Amino
Review
Disqualified: No funding amount provided.
San Francisco, California, USA
Amino is a data-driven healthcare guidance platform that helps companies and their employees navigate the complex US healthcare system.
BenchSci
Review
Disqualified: Funding amount is less than $100,000,000 and is not Series C financing or higher.
Toronto, Ontario, Canada
BenchSci uses machine learning and artificial intelligence to accelerate biomedical discoveries.
OpenFin
Review
Disqualified: Funding amount is lower than the required $100,000,000 or Series C financing or higher.
New York, New York, USA
OpenFin provides financial institutions with a unified workspace and developer platform built for productivity.
Qualified: The company meets all criteria for target industry and funding stage, but the funding amount is unknown.
Tel Aviv-yafo, Tel Aviv, Israel
Healthy.io converts smartphone cameras into a clinical grade medical device.
Fabrick
Review
Disqualified: No funding amount provided
Milan, Lombardia, Italy
Fabrick is a financial services company that offers solutions to provide their customers with a wide range of digital payments.
Clue
Review
Disqualified: Funding amount is not provided and the funding stage is Equity Crowdfunding, which does not meet the requirement of at least ~$100,000,000 or Series C financing or higher. Although the company is in the healthcare industry, it does not meet the target number of employees criteria of 50-500 employees.
Berlin, Berlin, Germany
Clue is a female health application for period and fertility tracking.
VectivBio
Review
Disqualified: Funding Amount is missing.
Basel, Switzerland
VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.
Enveda Biosciences
Review
Disqualified: The company does not meet the funding requirement of at least $100,000,000 or Series C financing or higher.
Boulder, Colorado, USA
Enveda Biosciences is a biotechnology company engineering new drugs from plants.
Hallow
Review
Disqualified: Funding amount does not meet the minimum requirement of ~$100,000,000 or Series C financing or higher.
Chicago, Illinois, USA
Hallow is a Catholic prayer and meditation app that hopes to help people grow closer to God.
Wefunder
Review
Disqualified: Funding amount is less than $100,000,000 and funding stage is only at the Seed level.
San Francisco, California, USA
Wefunder is a crowd investing platform that offers capital raising services.
Voyager
Review
Disqualified: The funding amount is less than $100,000,000 and the funding stage is Post-IPO Equity, which does not meet the criteria of at least Series C financing or higher.
Wilmington, Delaware, USA
Voyager offers a secure way to invest in cryptocurrencies and altcoins using its mobile application.
Liquid Death
Review
Disqualified: Funding amount is less than $100,000,000 and funding stage is Series D, which does not meet the funding criteria.
Santa Monica, California, USA
Liquid Death is a non-alcoholic beverage brand that is focused on health and sustainability.
Axuall
Review
Disqualified: The company does not meet the funding criteria. Its funding stage is Series B and funding amount is less than $100,000,000.
Cleveland, Ohio, USA
Axuall is a workforce intelligence company providing data and insights for network planning, analytics, and credentialing for healthcare.
Ensoma
Review
Disqualified: The company does not meet the funding criteria. Their funding stage is Series B and their funding amount is $1M to $10M, which is below the required financing of at least ~$100,000,000 or Series C financing or higher.
Boston, Massachusetts, USA
Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.
Vedanta Biosciences
Review
Disqualified: The funding amount is less than the required amount.
Cambridge, Massachusetts, USA
Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.
54gene
Review
Disqualified: Funding amount is not provided, and the funding stage is Series B which is lower than the required Series C or higher.
Washington, D.C., USA
54gene is a healthcare startup that offers a genetics testing platform.
Wysa
Review
Disqualified: Funding amount is not provided.
Bangalore, Karnataka, India
Wysa is a mental health wellness platform that helps individuals in managing their mental and emotional stress.
The Healthy Billion
Review
Disqualified: No funding amount provided.
Gurgaon, Haryana, India
The Healthy Billion is a clinical intelligence startup that enables healthcare using information technology.
Oshi Health
Review
Disqualified: Funding amount is below the minimum threshold of $100,000,000 for financing.
New York, New York, USA
Oshi Health is a digital health platform that provides personalized support and resources for people with digestive health conditions.
Colossal Biosciences
Review
Disqualified: Funding amount is not provided.
Dallas, Texas, USA
Colossal is a bioscience and genetic engineering company focused on de-extinction of past species.
Uwill
Review
Disqualified: No funding amount provided.
Natick, Massachusetts, USA
Uwill is an online therapy platform that connects college students to mental health professionals.
LIQUiDITY Group
Review
Disqualified: No funding amount provided.
New York, New York, USA
Liquidity Group is a fintech firm that specializes in providing non-dilutive, and unsecured capital to SaaS-based companies.
Disqualified: Funding amount is below the required threshold of $100,000,000 for financing.
1
Name: The EVERY Company
Last Funding Date: Feb 1
Number of employees: 51-100
Industries: Biotechnology, Food and Beverage, Food Processing, Manufacturing, Nutrition, Sustainability
Description: The EVERY Company makes real animal protein without the use of a single animal, starting with chicken-less egg proteins.
Funding Stage: Venture - Series Unknown
Funding Amount: —
Based on the given information, The EVERY Company could potentially be a good fit for the product given their focus on biotechnology and food processing. However, their funding stage and amount are unknown which may impact their eligibility for an interview. It is also important to note that they operate in multiple industries which may require a manual review.
1
The EVERY Company
Review
Disqualified: Target industry does not match any of the criteria. Manual review may be necessary as the company has potential in the technology industry but also operates in other industries. Funding information is not provided.
South San Francisco, California, USA
The EVERY Company makes real animal protein without the use of a single animal, starting with chicken-less egg proteins.
[Company]: Wellthy
[Last Funding Date]: May 11
[Number of Employees]: 251-500
[Industries]: Health Care, Medical, Wellness
[Description]: Wellthy is a family care concierge service that brings relief to families managing complex or ongoing care situations.
[Funding Stage]: Venture - Series Unknown
[Funding Amount]: $1M to $10M
Based on the statement [AI Analysis ✨], Wellthy is not disqualified for interview selection since its funding amount is greater than $100,000,000 and its funding stage is not known to be below Series C.
1
Manual Review: The company meets the target industries criteria, but it is unclear if the company specifically targets the finance industry. Additionally, there is no information on the funding amount which could impact the company's growth potential. However, the company's description suggests a strong focus on financial services and the funding stage is relatively advanced, indicating some level of success and stability. Further investigation is needed to determine if the company qualifies.
1
Cleo
Review
Manual Review: The company meets the target industries criteria, but there is no information on the funding amount. Additionally, the description mentions finance and financial services, but it is unclear if the company specifically targets the finance industry. Further investigation is needed to determine if the company qualifies.
London, England, UK
Cleo turns your complicated financial life into a conversation – the same kind you’d have with a friend.
Recursion Pharmaceuticals does not meet the funding criteria and is therefore disqualified. [AI Analysis ✨]
1
[Company]: MPOWER Financing
[Last Funding Date]: May 8
[Number of Employees]: 101-250
[Industries]: Finance, Financial Services, FinTech, Lending
[Description]: MPOWER Financing is a fintech company that provides educational loans to domestic and international students.
[Funding Stage]: Venture - Series Unknown
[Funding Amount]: $1M to $10M
Based on the given criteria, this company does not meet the funding requirements for a Series C or higher and has a funding amount less than $100,000,000. Therefore, it is disqualified for further consideration.
Statement: [AI Analysis ✨]
1
Based on the given company info, Marshmallow falls below the required minimum funding amount of $100,000,000 for financing and is at a funding stage of Series B, which is lower than the required Series C financing or higher. Therefore, it is disqualified for an interview.
```
[AI Analysis ✨]
Disqualified: The funding amount falls below the required minimum of $100,000,000 for financing, and the funding stage is Series B, which is lower than the required Series C financing or higher.
```
1
- [AI Analysis ✨]
Based on the provided information, YgEia3 does not meet the funding requirements for consideration. The company's funding amount is less than $100,000,000 and funding stage is not Series C or higher. Therefore, it is disqualified for further categorization and should be excluded from any interview considerations.
1
[AI Analysis ✨]
Since the funding amount of GetVantage is below the required threshold of at least $100,000,000 or Series C financing or higher, the company is disqualified for an interview.
1
- If the funding amount is below $100,000,000 or Series C financing or higher, return "Disqualified"
- If the funding stage is Series A or lower, prioritize the company as "Low"
- If the funding stage is Series B, prioritize the company as "Medium"
- If the funding stage is Series C or higher, prioritize the company as "High"
| Company | Last Funding Date | Number of Employees | Industries | Description | Funding Stage | Funding Amount | Priority |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cyclica | Nov 15 | 51-100 | Biotechnology, Health Care, Medical, Pharmaceutical | Cyclica is a company that creates patented cloud-based predictive analytics software to find safer and more effective medicines. | Series B | $1M to $10M | Medium |
1
Statement: [AI Analysis ✨]
###
1
Manual Review is needed to confirm if the funding amount is at least ~$100,000,000.
1
Allica Bank
Review
Qualified: The company meets the target industry criteria of Finance and the target funding criteria of Series C financing or higher. However, there is no information provided for funding amount. Manual Review is needed to confirm if the funding amount is at least ~$100,000,000.
London, England, UK
Allica Bank is a fintech company that delivers digital banking services for small and medium-sized businesses.
- Name: Memora Health
- Last Funding Date: Apr 18
- Number of employees: 101-250
- Industries: Health Care, Outpatient Care, Software
- Description: The leading intelligent care enablement platform to simplify how patients and clinicians navigate complex care delivery.
- Funding Stage: Venture - Series Unknown
- Funding Amount: $10M to $50M
1
Memora Health
Review
Disqualified: The company does not meet the funding criteria. Their funding amount is below the required ~$100,000,000 and they have not reached Series C financing or higher.
San Francisco, California, USA
The leading intelligent care enablement platform to simplify how patients and clinicians navigate complex care delivery.
- If funding amount is below $100,000,000 or if the funding stage is not Series C or higher: Disqualified
- Otherwise, the company is eligible for further evaluation based on the following categories:
- Last Funding Date: Jun 8
- Number of employees: 51-100
- Industries: Education, Health Care, Home Health Care, SaaS, Training
- Description: CareAcademy offers an online training empowering senior care professionals to deliver the highest caliber of services.
- Funding Stage: Series B
- Funding Amount: $1M to $10M
[AI Analysis ✨]
1
- [AI Analysis ✨]
- Name: IVERIC bio
- Last Funding Date: Nov 30
- Number of employees: 101-250
- Industries: Biotechnology, Health Care, Pharmaceutical
- Description: IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
- Funding Stage: Post-IPO Equity
- Funding Amount: $100M to $500M
1
- Name: Augmedix
- Last Funding Date: Apr 20
- Number of employees: 251-500
- Industries: Electronic Health Record (EHR), Health Care, Hospital, Medical
- Description: Augmedix is an automated medical documentation and data services for healthcare systems, hospitals, practices, and more.
- Funding Stage: Post-IPO Equity
- Funding Amount: $10M to $50M
[AI Analysis ✨]
1
- If funding amount is below $100,000,000 or Series C financing or higher, return:
[AI Analysis ✨] Disqualified: Funding amount is below the required threshold of $100,000,000 or Series C financing or higher.
- For companies that meet funding requirements, prioritize based on the following categories in order of importance:
1. Industries (Health Care, Information Technology, SaaS, Software)
2. Last Funding Date (more recent is better)
3. Number of employees (larger is better)
4. Funding Stage (later stage is better)
5. Funding Amount (higher amount is better)
- Return the prioritized list of companies.
1
Krystal Biotech is disqualified for funding amount below the required threshold of $100,000,000.
1
Based on the provided information, Northern Arc would not be prioritized for an interview due to their funding stage and amount falling below the criteria of at least Series C funding and $100,000,000 in funding. Therefore, the output is:
[AI Analysis ✨]
1
[Company]: Inbox Health
[Last Funding Date]: May 4
[Number of Employees]: 101-250
[Industries]: Billing, Health Care, Payments, Software
[Description]: Inbox Health is a digital healthcare company that designs a tool to automate bills and give patients additional insights into their charges.
[Funding Stage]: Series B
[Funding Amount]: $1M to $10M
Based on the given information, Inbox Health does not meet the funding requirements for the product and is disqualified. Therefore, the statement to return is:
"[AI Analysis ✨]"
1
According to the provided information, the company HeartFlow would not meet the minimum funding requirement for financing or Series C financing or higher, and therefore is disqualified. Therefore, the output should be:
[AI Analysis ✨]
1
- Name: Cedar
- Last Funding Date: Dec 19
- Number of employees: 101-250
- Industries: Billing, FinTech, Health Care, Medical, Payments
- Description: Cedar is a patient payment and engagement platform for hospitals, health systems, and medical groups that elevates the patient experience.
- Funding Stage: Series D
- Funding Amount: $1M to $10M
[AI Analysis ✨]
1
[Company]: Monese
Based on the provided information, Monese has a funding stage of Venture - Series Unknown and a funding amount of $1M to $10M, which is below the required threshold of $100,000,000 or Series C financing or higher. Therefore, based on the given statement, Monese is disqualified for consideration for an interview.
[AI Analysis ✨]: Disqualified: Funding amount is below the required threshold of $100,000,000 or Series C financing or higher.
1
Want to print your doc?
This is not the way.
This is not the way.
Try clicking the ··· in the right corner or using a keyboard shortcut (
CtrlP
) instead.